drugset / Trial / NCT01651663

A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common Cold

NCT01651663

Phase 4 Unknown 840 enrolled Pharmstandard
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Arbidol (Umifenovir) is effective in the treatment and Prophylaxis of Influenza and Common Cold

Timeline

Start
2011-09
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Umifenovir Small molecule 200 mg
Subject Umifenovir Small molecule 800 mg

Indications